Background: Serdemetan is a compound that can cause replicative stress type responses in tumor cells and it has been administered to patients with solid tumors. ECG data from an ongoing first-in-human ...
Drug developers face unique challenges in pediatric rare disease trials, including small and geographically dispersed patient populations, strict ethical limits on sampling and sparse early clinical ...
Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting ...
PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of Phoenix 8.0. Phoenix is the most advanced, ...
The series, sponsored by the University at Buffalo Center of Excellence in Pharmacokinetics and Pharmacodynamics, consisted of four specialized courses: The original PK/PD workshop was established in ...
CONCORD, Mass., Jan. 10, 2023 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate ...
Applied BioMath, the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk and accelerate drug research and development, announced a collaboration with Revitope for an ...
Quantitative systems pharmacology (QSP) is a field of biomedical research that aims to model the mechanisms behind disease progression and quantify the pharmacokinetics and pharmacodynamics of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results